Portfolio company
NeuraLight
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Neuronostics
The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.
BeCareLink
This company develops mobile applications using artificial intelligence to monitor and assess neurological functions for patients and healthcare providers.
Brightlamp
This company develops a mobile pupillometry application for medical professionals to assess neurological conditions and traumatic brain injuries through pupillary light reflex measurements.
Brooklyn Health
This neuroscience technology company develops an artificial intelligence platform to provide objective mental health measurement for pharmaceutical companies conducting clinical trials.
NyraHealth
This company develops AI-powered speech and memory therapy software for neurological patients, clinics, and therapeutic practices.
Neurotrack
Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.
Neu Health
This company develops a digital neurology platform for Parkinson's disease and dementia patients and clinicians to monitor symptoms and manage care remotely.
